Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05282927 · ClinicalTrials.gov registry record · NA

Implementing Group Physical Therapy (PT) for Veterans With Knee Osteoarthritis (Group PT): Function QUERI 2.0

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
19
Enrollment target

NCT05282927: Completed NA study, sponsored by VA Office of Research and Development.

NCT05282927 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05282927, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target

Study Summary

Implementing Group Physical Therapy (PT) for Veterans with Knee Osteoarthritis (OA): Function QUERI 2.0 (Group PT) aims to implement, evaluate and sustain Group PT in 16 VA sites using a type III effectiveness-implementation hybrid design framework, which will compare implementation strategies while also gathering information about the clinical intervention and related outcomes.

Primary Outcome

Penetration is defined as the average number of patients enrolling in the group physical therapy (PT) program on a monthly basis (defined as completing at least one class).

Interventions

  • OTHER Implementation Strategy: Foundational REP
  • OTHER Implementation Strategy: Enhanced REP (enREP)

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2022-06-21
Est. Completion 2024-05-18
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT05282927 record still lists

NCT05282927 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Implementation Strategy: Foundational REP is the first listed.

NCT05282927 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05282927 about?

NCT05282927 is a clinical study titled "Implementing Group Physical Therapy (PT) for Veterans With Knee Osteoarthritis (Group PT): Function QUERI 2.0". Implementing Group Physical Therapy (PT) for Veterans with Knee Osteoarthritis (OA): Function QUERI 2.0 (Group PT) aims to implement, evaluate and sustain Group PT in 16 VA sites using a type III effectiveness-implementation hybrid design framework, which will compare implementation strategies while...

What is the current status of trial NCT05282927?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2022-06-21. Estimated completion is 2024-05-18.

What interventions are being tested in trial NCT05282927?

The interventions under investigation include: Implementation Strategy: Foundational REP (OTHER), Implementation Strategy: Enhanced REP (enREP) (OTHER).

Who is sponsoring clinical trial NCT05282927?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05282927's enrollment target sits among peer trials

19 1861st of 2000 higher than 138 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05282927, the US trial registry maintained by the National Library of Medicine. NCT05282927 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.